| Trial ID: | L1321 |
| Source ID: | NCT03082625
|
| Associated Drug: |
Transdermal Magnesium
|
| Title: |
Topical Magnesium and Muscle Cramps in Dialysis Patients.
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Diseases|End Stage Renal Disease|Dialysis Related Complications
|
| Interventions: |
DRUG: Transdermal Magnesium|DRUG: Placebo
|
| Outcome Measures: |
Primary: Difference in the average number of muscle cramps per week between magnesium and placebo treatments, final 3 weeks, 3 weeks | Secondary: Difference in average cramp duration between magnesium and placebo treatments, final 3 weeks, 3 weeks|Difference in average cramp severity between magnesium and placebo treatments, final 3 weeks, 3 weeks|Percentage change in serum magnesium concentration from baseline and at the end of each treatment stage, 3 weeks|Difference in restless legs symptoms between the magnesium and placebo treatment stages., 3 weeks
|
| Sponsor/Collaborators: |
Sponsor: Sir Charles Gairdner Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
40
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2017-05-01
|
| Completion Date: |
2018-12-31
|
| Results First Posted: |
|
| Last Update Posted: |
2017-03-17
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT03082625
|
